These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 26812060)
1. Innate lymphoid cells and the MHC. Robinette ML; Colonna M HLA; 2016 Jan; 87(1):5-11. PubMed ID: 26812060 [TBL] [Abstract][Full Text] [Related]
2. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions. Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L Front Immunol; 2019; 10():910. PubMed ID: 31105707 [TBL] [Abstract][Full Text] [Related]
3. Porcine T lymphocytes and NK cells--an update. Gerner W; Käser T; Saalmüller A Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948 [TBL] [Abstract][Full Text] [Related]
4. Teleost T and NK cell immunity. Fischer U; Koppang EO; Nakanishi T Fish Shellfish Immunol; 2013 Aug; 35(2):197-206. PubMed ID: 23664867 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua. Vacca P; Chiossone L; Mingari MC; Moretta L Front Immunol; 2019; 10():170. PubMed ID: 30800126 [TBL] [Abstract][Full Text] [Related]
6. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Liao NS; Bix M; Zijlstra M; Jaenisch R; Raulet D Science; 1991 Jul; 253(5016):199-202. PubMed ID: 1853205 [TBL] [Abstract][Full Text] [Related]
7. Innate Lymphoid Cells in Human Pregnancy. Mendes J; Areia AL; Rodrigues-Santos P; Santos-Rosa M; Mota-Pinto A Front Immunol; 2020; 11():551707. PubMed ID: 33329512 [TBL] [Abstract][Full Text] [Related]
8. NK Cell Development in Times of Innate Lymphoid Cell Diversity. Stokic-Trtica V; Diefenbach A; Klose CSN Front Immunol; 2020; 11():813. PubMed ID: 32733432 [TBL] [Abstract][Full Text] [Related]
9. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923 [TBL] [Abstract][Full Text] [Related]
11. CD160: a unique activating NK cell receptor. Le Bouteiller P; Tabiasco J; Polgar B; Kozma N; Giustiniani J; Siewiera J; Berrebi A; Aguerre-Girr M; Bensussan A; Jabrane-Ferrat N Immunol Lett; 2011 Aug; 138(2):93-6. PubMed ID: 21324341 [TBL] [Abstract][Full Text] [Related]
12. The Development and Diversity of ILCs, NK Cells and Their Relevance in Health and Diseases. Zhang Y; Huang B Adv Exp Med Biol; 2017; 1024():225-244. PubMed ID: 28921473 [TBL] [Abstract][Full Text] [Related]
13. Protocols for Innate Lymphoid Cell Phenotypic and Functional Characterization: An Overview. Amarnath S Methods Mol Biol; 2020; 2121():1-6. PubMed ID: 32147781 [TBL] [Abstract][Full Text] [Related]
14. Lymphoid tissue inducer-A divergent member of the ILC family. Zhong C; Zheng M; Zhu J Cytokine Growth Factor Rev; 2018 Aug; 42():5-12. PubMed ID: 29454785 [TBL] [Abstract][Full Text] [Related]
15. Licensing of killer dendritic cells in mouse and humans: functional similarities between IKDC and human blood γδ T-lymphocytes. Anderson J; Gustafsson K; Himoudi N J Immunotoxicol; 2012; 9(3):259-66. PubMed ID: 22632132 [TBL] [Abstract][Full Text] [Related]
16. Mouse models for the study of fate and function of innate lymphoid cells. Cording S; Medvedovic J; Lécuyer E; Aychek T; Déjardin F; Eberl G Eur J Immunol; 2018 Aug; 48(8):1271-1280. PubMed ID: 29974461 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the natural killer cell receptor repertoire. Raulet DH; Vance RE; McMahon CW Annu Rev Immunol; 2001; 19():291-330. PubMed ID: 11244039 [TBL] [Abstract][Full Text] [Related]
18. The role of helper innate lymphoid cells in cancer. Hu S; Wang X Immunotherapy; 2019 Aug; 11(12):1067-1081. PubMed ID: 31238781 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cells and type 1 innate lymphoid cells in cancer. Lopes N; Vivier E; Narni-Mancinelli E Semin Immunol; 2023 Mar; 66():101709. PubMed ID: 36621291 [TBL] [Abstract][Full Text] [Related]
20. Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer. Calvi M; Di Vito C; Frigo A; Trabanelli S; Jandus C; Mavilio D Front Immunol; 2022; 13():914266. PubMed ID: 35720280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]